The Promise of EZH2 Inhibitors in Rare and Aggressive Cancers 
 A potential family of medications known as EZH2 inhibitors is made to specifically target and alter the activity of EZH2, a crucial protein involved in the regulation of genes and other biological processes. Enhancer of Zeste Homolog 2, or EZH2, is a part of the polycomb repressive complex 2 (PRC2), which is essential for preserving cellular identity and gene silence. Since this protein is...
     0 Comments
               0 Shares
              
  
  
  
  Arabic
Arabic
             French
French
             Spanish
Spanish
             Portuguese
Portuguese
             Deutsch
Deutsch
             Turkish
Turkish
             Dutch
Dutch
             Italiano
Italiano
             Russian
Russian
             Romaian
Romaian
             Portuguese (Brazil)
Portuguese (Brazil)
             Greek
Greek